EXAGEN INC. - COMMON STOCK

Exagen to Announce Fourth Quarter and Full Year Financial Results on March 20, 2023

06 Mar 2023 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in Upcoming March Conferences

27 Feb 2023 09:00:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the 2023 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

30 Jan 2023 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Elects Tina S. Nova, Ph.D. as Executive Chair of the Board of Directors

23 Jan 2023 09:00:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Third Quarter 2022 Results

14 Nov 2022 16:05:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in Fourth Quarter Investor Conferences

08 Nov 2022 16:05:02 By Nasdaq GlobeNewswire

Exagen to Announce Third Quarter 2022 Financial Results on November 14, 2022

31 Oct 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Announces Appointment of John Aballi as CEO

17 Oct 2022 09:00:00 By Nasdaq GlobeNewswire

Exagen Announces Appointment of Andrew L. Concoff MD, FACR, CAQSM, as Chief Innovation Officer

04 Oct 2022 08:25:00 By Nasdaq GlobeNewswire

Exagen Announces Acceptance of Multiple Abstracts at ACR 2022 Annual Meeting

20 Sep 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Collaboration Leads to Characterization of Broad Autoreactivity in Severe COVID-19 Patients

01 Sep 2022 16:05:01 By Nasdaq GlobeNewswire

Exagen Initiates Study to Predict Rheumatoid Arthritis Drug Response (RADR) in Patients with RA

04 Aug 2022 16:06:00 By Nasdaq GlobeNewswire

Exagen Inc. Reports Second Quarter 2022 Results

04 Aug 2022 16:05:01 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the Canaccord Genuity 42nd Annual Growth Conference

25 Jul 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen to Announce Second Quarter 2022 Financial Results on August 4, 2022

21 Jul 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Releases Largest Comparative Utility Study in Lupus Diagnostics Confirming AVISE® Lupus Delivers Unparalleled Utility

05 Jul 2022 08:25:00 By Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with MediNcrease

09 Jun 2022 08:25:00 By Nasdaq GlobeNewswire

Exagen Inc. to Participate in the William Blair 42nd Annual Growth Stock Conference

26 May 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Expands Coverage with Alivio Health, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE® Lupus

16 May 2022 16:05:00 By Nasdaq GlobeNewswire

Exagen Inc. Announces New PLA Code and Medicare Pricing for Proprietary AVISE® Lupus Test

11 May 2022 16:06:00 By Nasdaq GlobeNewswire